N-glycosylation Dictates Proper Processing of Organic Anion Transporting Polypeptide 1B1

被引:36
|
作者
Yao, Juan [1 ]
Hong, Weifang [1 ]
Huang, Jiujiu [1 ]
Zhan, Kai [1 ]
Huang, Hong [2 ]
Hong, Mei [1 ]
机构
[1] S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China
[2] Univ S Florida, Sch Informat, Tampa, FL USA
来源
PLOS ONE | 2012年 / 7卷 / 12期
基金
中国国家自然科学基金;
关键词
OATP TRANSPORTERS; DRUG; MEMBRANE; POLYMORPHISMS; DISPOSITION; KIDNEY; IMPACT; CELLS;
D O I
10.1371/journal.pone.0052563
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Organic anion transporting polypeptides (OATPs) have been extensively recognized as key determinants of absorption, distribution, metabolism and excretion (ADME) of various drugs, xenobiotics and toxins. Putative N-glycosylation sites located in the extracellular loops 2 and 5 is considered a common feature of all OATPs and some members have been demonstrated to be glycosylated proteins. However, experimental evidence is still lacking on how such a post-translational modification affect the transport activity of OATPs and which of the putative glycosylation sites are utilized in these transporter proteins. In the present study, we substituted asparagine residues that are possibly involved in N-glycosylation with glutamine residues and identified three glycosylation sites (Asn134, Asn503 and Asn516) within the structure of OATP1B1, an OATP member that is mainly expressed in the human liver. Our results showed that Asn134 and Asn516 are used for glycosylation under normal conditions; however, when Asn134 was mutagenized, an additional asparagine at position 503 is involved in the glycosylation process. Simultaneously replacement of all three asparagines with glutamines led to significantly reduced protein level as well as loss of transport activity. Further studies revealed that glycosylation affected stability of the transporter protein and the unglycosylated mutant was retained within endoplasmic reticulum.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Organic Anion Transporting Polypeptide (OATP)1B1 and OATP1B3 as Important Regulators of the Pharmacokinetics of Substrate Drugs
    Maeda, Kazuya
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (02) : 155 - 168
  • [32] Frequency of organic anion transporting polypeptide 1B1 SLCO1B1 gene variants in populations of patients treated with atorvastatin
    Daka, A.
    Nestorovska, A. K.
    Radivojsa, I.
    Mladenovska, K.
    Vavlukis, M.
    Dimovski, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 992 - 992
  • [33] Inhibition of Organic Anion Transporting Polypeptide 1B1 and 1B3 by Betulinic Acid: Effects of Preincubation and Albumin in the Media
    Oh, Yunseok
    Jeong, Yoo-Seong
    Kim, Min-Soo
    Min, Jee Sun
    Ryoo, Gongmi
    Park, Ji Eun
    Jun, Yearin
    Song, Yoo-Kyung
    Chun, Se-Eun
    Han, Songhee
    Bae, Soo Kyung
    Chung, Suk-Jae
    Lee, Wooin
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (06) : 1713 - 1723
  • [34] Modeling Organic Anion-Transporting Polypeptide 1B1 Inhibition to Elucidate Interaction Risks in Early Drug Design
    Zamora, Ismael
    Winiwarter, Susanne
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (10) : 3214 - 3220
  • [35] Untargeted metabolomics and machine learning for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function
    Hamalainen, Kreetta
    Neuvonen, Mikko
    Hirvensalo, Paivi
    Lehtonen, Marko
    Auriola, Seppo
    Tornio, Aleksi
    Backmann, Janne
    Niemi, Mikko
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 386 - 386
  • [36] Non-targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function
    Hamalainen, Kreetta
    Hirvensalo, Paeivi
    Neuvonen, Mikko
    Tornio, Aleksi
    Backman, Janne T.
    Lehtonen, Marko
    Niemi, Mikko
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (03):
  • [37] Polymorphism of the hepatic influx transporter organic anion transporting polypeptide 1B1 is associated with increased cholesterol synthesis rate
    Pasanen, Marja K.
    Miettinen, Tatu A.
    Gylling, Helena
    Neuvonen, Pertti J.
    Niemi, Mikko
    PHARMACOGENETICS AND GENOMICS, 2008, 18 (10): : 921 - 926
  • [38] Influence of Rifampin-Mediated Organic Anion-Transporting Polypeptide 1B1/1B3 Inhibition on the Pharmacokinetics of Clazosentan
    Juif, Pierre-Eric
    Voors-Pette, Christine
    Ufer, Mike
    Dogterom, Peter
    Dingemanse, Jasper
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, 12 (05): : 440 - 444
  • [39] Evaluation of Organic Anion Transporting Polypeptide 1B1 and 1B3 Humanized Mice as a Translational Model to Study the Pharmacokinetics of Statins
    Salphati, Laurent
    Chu, Xiaoyan
    Chen, Liangfu
    Prasad, Bhagwat
    Dallas, Shannon
    Evers, Raymond
    Mamaril-Fishman, Donna
    Geier, Ethan G.
    Kehler, Jonathan
    Kunta, Jeevan
    Mezler, Mario
    Laplanche, Loic
    Pang, Jodie
    Rode, Anja
    Soars, Matthew G.
    Unadkat, Jashvant D.
    van Waterschoot, Robert A. B.
    Yabut, Jocelyn
    Schinkel, Alfred H.
    Scheer, Nico
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (08) : 1301 - 1313
  • [40] Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population
    Marja K. Pasanen
    Janne T. Backman
    Pertti J. Neuvonen
    Mikko Niemi
    European Journal of Clinical Pharmacology, 2006, 62 : 409 - 415